Kalkman H O, Schneider F
Preclinical Research, Sandoz Pharma Ltd., Basel, Switzerland.
Pharmacology. 1996 Dec;53(6):351-5. doi: 10.1159/000139450.
Ergotamine contracted isolated rat aorta rings with an intrinsic activity of 50% of that of 5-hydroxytryptamine. (5-HT, 0.1 mmol/l). Dihydroergotamine did not contract the tissue, but insurmountably blocked contraction in response to ergotamine and 5-HT. The 5-HT2A receptor antagonist, ketanserin (0.1 mumol/l), inhibited ergotamine (pKB 8.0) and 5-HT (pKB 8.1) induced contractions. These results indicate that in the rat aorta ergotamine is a partial 5-HT2A receptor agonist, whilst dihydroergotamine is an insurmountable 5-HT2A receptor antagonist. The present data could explain why ergotamine displays more cardiovascular and uterotonic side effects than dihydroergotamine.
麦角胺能使离体大鼠主动脉环收缩,其内在活性为5-羟色胺(5-HT,0.1 mmol/l)的50%。二氢麦角胺不会使组织收缩,但能不可逾越地阻断对麦角胺和5-HT的收缩反应。5-HT2A受体拮抗剂酮色林(0.1 μmol/l)能抑制麦角胺(pKB 8.0)和5-HT(pKB 8.1)诱导的收缩。这些结果表明,在大鼠主动脉中,麦角胺是一种部分5-HT2A受体激动剂,而二氢麦角胺是一种不可逾越的5-HT2A受体拮抗剂。目前的数据可以解释为什么麦角胺比二氢麦角胺表现出更多的心血管和子宫收缩副作用。